Eli Lilly LLY announced results from the phase III EMBER-3 study, which showed that treatment with its orally administered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback